Iron and aging

Iron is essential for life and impossible for the body to excrete — so in adults who aren't losing blood, it slowly accumulates and quietly fuels the oxidative damage that drives aging. The practical upshot for a healthy midlife adult is narrow and well-supported: don't supplement iron unless you're deficient, keep ferritin in the lower half of the "normal" range, and treat high-normal iron as a signal, not a comfort.

Iron sits at the centre of an evolutionary trade-off. Its ability to flip between two charge states (Fe²⁺ and Fe³⁺) is what makes it indispensable — for carrying oxygen in haemoglobin, for the electron-transport chain that produces cellular energy, for dozens of enzymes. The same chemistry makes loose iron dangerous: it catalyses the production of the most destructive free radical in biology. Humans evolved under iron scarcity and frequent blood loss, so the body has elaborate machinery to absorb and hoard iron but no regulated pathway to get rid of it. Once childhood growth and (in women) menstruation end, iron tends to creep upward for the rest of life — steadily in men, and in women after menopause, though women often never reach male levels — and the genetic evidence now links that creep to a measurably shorter lifespan.^[1]

Why iron is a longevity problem

The strongest human evidence comes from genetics. Large genome-wide studies pooling more than 1.75 million lifespans found that gene sets controlling blood-iron metabolism were over-represented among the regions associated with long life, healthspan, and extreme longevity.^[2] Because inherited gene variants are randomly assigned at conception and fixed for life, comparing people by their genetically-predicted iron level (Mendelian randomization) sidesteps most of the confounding that plagues diet-and-disease studies. For the endpoint that matters most here — total lifespan — the signal is one-directional: each standard-deviation increase in genetically-predicted serum iron was associated with roughly 0.7 fewer years of lifespan and lower odds of surviving into the oldest age bands.^[3]

The disease-by-disease picture is not a single arrow, and it's worth stating plainly — Moderate genetic evidence. Higher genetically-predicted iron actually lowers the risk of coronary artery disease^[4] and, counterintuitively given the iron that accumulates in Parkinsonian brains, of Parkinson's disease — about a 3% relative reduction per 10 µg/dL of serum iron, a direction the authors themselves flag as surprising and not yet clinically actionable.^[5] It raises the risk of type 2 diabetes and of cardioembolic stroke. The honest one-line summary is that the net effect on lifespan is negative even though the disease-specific effects diverge — a reminder that "iron is bad" is too blunt, and that systemic iron and tissue iron can move in opposite directions.

This is causal-inference evidence, not a randomized trial, and the effect per unit is modest. But it converges with basic biochemistry and with the simple fact that the body cannot offload iron — which is why iron now appears on most maps of the hallmarks of aging, tied to genomic instability, mitochondrial decline, and cellular senescence.

How excess iron damages cells

Inside a healthy cell, almost all iron is locked inside ferritin, a hollow protein shell that holds thousands of iron atoms in a chemically inert form, releasing them only on demand. Aging erodes that control, and free iron does its damage through one reaction.

The Fenton reaction. Normal respiration constantly produces small amounts of hydrogen peroxide. On its own it is mild. But in the presence of loose Fe²⁺ it is converted into the hydroxyl radical — the most reactive oxidant the body generates, with no enzyme to neutralise it. It indiscriminately shreds the nearest molecules: peroxidising membrane fats, misfolding proteins, and breaking DNA strands.^[6] Mitochondria, which both consume the most iron and sit closest to the leak, take the worst of it — a self-reinforcing loop of damage, more leakage, and falling energy output.

Nutrient sensing and autophagy. Beyond direct oxidation, iron acts as a growth signal that helps keep the growth-sensing mTOR pathway (mechanistic target of rapamycin) switched on. Sustained mTOR activity in adulthood suppresses autophagy — the cellular recycling that clears damaged mitochondria and protein junk — and is itself a recognised pro-aging driver (the same pathway that calorie restriction and rapamycin act on; see protein). In worms and mice, restricting iron switches on stress-resistance and recycling programmes and extends lifespan, mirroring those interventions.^[7]

Ferrosenescence — Weak / preliminary. A newer and still largely preclinical idea is "ferrosenescence": senescent (worn-out but un-dying) cells accumulate large amounts of iron, but trap it inside undegradable ferritin, which paradoxically makes them resist the iron-dependent cell death (ferroptosis) that might otherwise clear them. They persist instead, leaking inflammatory signals.^[8] The mechanism is plausible and actively researched, but it is animal- and cell-level work — treat it as a hypothesis, not an established target. Ferroptosis itself — iron-driven cell death through runaway oxidation of membrane fats — is implicated across neurodegeneration, heart failure, and joint disease, but the human evidence is associative and no ferroptosis-targeting therapy is approved for any aging condition; it is a mechanistic frontier, not a lever.

The natural experiment: hereditary haemochromatosis — Strong. The clearest human demonstration that chronic iron excess causes cumulative damage comes from people who inherit two faulty copies of the HFE gene (about 1 in 150 of European ancestry), which lets iron load without limit. In a large UK cohort followed for years, these men carried excess all-cause mortality and dramatically more liver disease, joint replacements, and even excess dementia, delirium, and Parkinson's disease, with a roughly tenfold rise in liver cancer — and the excess harm showed up even in those never formally diagnosed.^[9] Because the damage is largely preventable by regular blood-letting to keep iron down, it is a clean, hard-outcome anchor for the whole chronic-excess thesis.

The iron–heart hypothesis

In 1981 the pathologist Jerome Sullivan proposed that the reason premenopausal women have far less heart disease than men is not estrogen but iron: monthly menstrual blood loss keeps their iron stores low, and the protection fades after menopause as iron climbs.^[10] The mechanism is coherent — stored iron catalyses the oxidation of LDL cholesterol, and it is oxidised LDL that macrophages engulf to form the foam cells at the core of arterial plaque.

The epidemiology is supportive but the interventional evidence is not. The one large randomized test of the idea — the FeAST trial, which used repeated phlebotomy to lower iron in patients with peripheral artery disease — found no overall reduction in mortality or cardiovascular events: all-cause death and the combined death-heart-attack-stroke endpoint were both statistically null.^[11] A pre-specified subgroup — the youngest quartile, roughly ages 43 to 61 — did show markedly fewer deaths and events, but this is a subgroup finding inside an overall-negative trial and should be read as hypothesis-generating, not as a green light to bleed toward benefit. So the honest reading is: avoiding iron overload is sound, but the claim that actively bleeding healthy people prevents heart attacks is not established by randomized data. This is the central calibration point of the whole topic — the genetic and mechanistic case is stronger than the treatment case.

Brain iron and neurodegeneration

The brain is unusually exposed. It burns oxygen heavily, is rich in the polyunsaturated fats that lipid peroxidation attacks, and accumulates iron with age in exactly the regions tied to movement and cognition — the substantia nigra and basal ganglia. This is not passive: in aging mice, the cortex ramps up production of hepcidin, the hormone that destroys the cell's only iron exporter, effectively trapping iron inside brain cells.^[12]

Excess iron is a recurring feature across neurodegenerative disease: it concentrates in the substantia nigra in Parkinson's, and it accelerates the aggregation and toxicity of amyloid and tau in Alzheimer's.^[13] But association is not causation, and the blood–brain barrier means whole-body iron offloading (e.g. blood donation) does little for brain iron.

The trials that lowered brain iron backfired — Moderate. This is the crucial calibration for anyone tempted to treat brain iron as a lever. Two well-run randomized trials used deferiprone, a drug that crosses into the brain and does lower brain iron, and both made outcomes worse, not better. In newly-diagnosed, untreated Parkinson's disease, deferiprone cut brain iron on MRI but produced worse movement scores than placebo over 36 weeks — probably because iron is needed to make dopamine, so chelating it in untreated patients starves dopamine synthesis.^[14] In amyloid-confirmed early Alzheimer's, deferiprone likewise lowered brain iron but accelerated cognitive decline over a year, with greater frontal brain-volume loss.^[15] The one clear exception is pantothenate-kinase-associated neurodegeneration, a rare inherited brain-iron-overload disease in which deferiprone does help — but that is a genetic overload disorder, not ordinary aging. So iron is one thread in dementia risk, not a proven lever, and in the brain the trial evidence argues actively against lowering it — the established levers live under dementia prevention.

Dietary iron: heme vs. non-heme

Where iron comes from matters more than the headline milligram total.

Heme iron — from red meat, poultry, and fish — is absorbed at 15–35% through a dedicated pathway that the body cannot down-regulate when stores are already full. It is also a pro-oxidant in the gut. Heme iron tracks with type 2 diabetes and cardiometabolic disease in a clean dose-response, and it appears to mediate much of the diabetes risk attributed to red meat.^[16] The colorectal-cancer angle is covered under red and processed meat.
Non-heme iron — from plants and fortified foods — is absorbed less efficiently (2–20%) and, crucially, is regulated: the gut takes up less when stores are adequate. In cohort data, higher non-heme iron intake is neutral-to-protective rather than harmful.

Because non-heme absorption is regulated and modifiable, it's also controllable at the table. Polyphenols and tannins (in tea, coffee, cocoa) and phytates (in legumes and whole grains) bind non-heme iron and can cut its absorption by up to half — see tea and coffee. Vitamin C does the opposite, sharply increasing absorption. So the iron-deficient should pair plant iron with citrus and away from tea; the iron-replete adult can do the reverse without effort.

Supplements are the sharp end — Caution. Iron supplements deliver a large, unregulated bolus. In healthy, non-deficient adults they offer no benefit and a real harm signal: cohort work links supplement-driven iron overload to faster biological aging through inflammatory markers. Don't take iron without a documented deficiency.

Biomarkers: what to actually measure

Standard lab reference ranges are built to catch overt anaemia or full iron-overload disease, not to optimise aging — they tolerate a lot of accumulation before flagging anything. Two cheap tests carry most of the signal, and both have a U-shape: too little is as bad as too much.

Marker	Standard "normal"	Longevity-oriented target	Why it matters
Ferritin (stored iron)	~10–300+ µg/L	45–80 µg/L (premenopausal women) · 60–120 µg/L (men, postmenopausal women)	High-normal correlates with oxidative stress and shorter survival; very low impairs energy, endurance, cognition
Transferrin saturation (iron in transit)	20–50%	24–40%	Above ~55% raises all-cause mortality (about 60% higher in cohort data); below 20% signals deficiency and inflammation

A practical caveat: ferritin is also an inflammation marker, so a high reading must be interpreted alongside an inflammation marker (hs-CRP, high-sensitivity C-reactive protein) and transferrin saturation before being called iron overload. If ferritin is high with normal inflammation and saturation above ~45%, a hereditary haemochromatosis work-up is appropriate. The full panel and how to read it sit in midlife labs.

Supporting (not decisive) evidence: people who reach 100 tend to carry lower ferritin than their 80-something peers, alongside generally "younger" blood chemistry.^[17] This is observational and the differences are small — consistent with the iron story, not proof of it.

What to do

Ranked by evidence-to-effort for a healthy midlife adult:

Don't supplement iron unless a blood test shows deficiency. This is the single highest-yield rule. Multivitamins-with-iron are unnecessary for most non-menstruating adults.
Measure ferritin and transferrin saturation every 1–2 years and aim for the lower half of normal (see table). Interpret a high ferritin against hs-CRP.
Moderate heme iron. Keep unprocessed red meat occasional rather than daily; the protein and B12 are available from fish, poultry, and plants with less pro-oxidant load.
Use ordinary dietary levers. Tea or coffee with iron-rich meals lowers non-heme absorption; save vitamin-C pairing for when you actually want more iron.
Blood donation is reasonable and pro-social, within limits. It reliably lowers iron stores. The mortality benefits claimed in donor studies are heavily confounded by the "healthy donor effect," so donate because it helps others and modestly offloads iron — not as a proven longevity treatment. Cap it at roughly 3–4 times a year for men and 1–2 for premenopausal women, with at least ~12 weeks between sessions, and monitor ferritin so you don't tip into deficiency.

What's overrated

Aggressive phlebotomy as anti-aging therapy. The randomized data (FeAST) didn't show the mortality benefit the hypothesis predicts. Offloading overload is sensible; bleeding toward deficiency is not.
Iron-chelator supplements (EGCG, quercetin) for "brain detox." Green-tea EGCG (epigallocatechin gallate) does chelate iron and crosses into the brain in lab models,^[18] but the human evidence for slowing neurodegeneration by this route is preliminary. Drinking tea is fine; high-dose EGCG extracts carry liver-toxicity risk and aren't a proven neuroprotectant.
Precise dietary "breakpoints." Single studies put the harm threshold at oddly exact figures (e.g. 18.4 mg/day); the real signal is the heme/supplement source and the body's stored level, not a decimal-point intake target.

Cautions

Deficiency is the more common everyday problem, especially in premenopausal women, endurance athletes, frequent donors, and long-term plant-based eaters. Low iron causes fatigue, hair loss, poor exercise recovery, restless legs, and impaired cognition — sometimes before ferritin drops below the old <15–30 µg/L cutoffs. The modern threshold for treating deficiency is being raised toward <50 µg/L.^[19] The goal is low-normal, not empty.
In older adults, the deficiency side of the U becomes a serious clinical problem — Strong for prevalence. Anemia affects roughly one in ten community-dwelling people over 65 and more than one in five past 85, with far higher rates in hospital and nursing homes.^[20] Even mild anemia independently tracks with higher mortality in this age group, and US deaths with iron-deficiency anemia listed as a cause in people over 65 have been rising over the past two decades.^[21] Iron deficiency is only part of the picture — it accounts for roughly one-sixth of anemia cases in the elderly, with inflammation, kidney disease, and an unexplained group making up the rest — so don't equate "anemia in an older adult" with "needs iron." Two distinct problems hide behind the same low serum iron: true iron-deficiency anemia (real depletion, which needs replacement) versus anemia of chronic inflammation (functional iron restriction driven by the hormone hepcidin, in which supplementing does nothing useful and may cause harm). Because a low ferritin can also flag occult bleeding or malignancy, low iron in an older adult is a reason for a clinical work-up, not a reason to self-treat.
Don't act on a single ferritin value during illness or hard training — both inflate it.
This is general information, not a prescription. Hereditary haemochromatosis, anaemia, and kidney disease all change the calculus and need clinical management.